$16.91
-1.08-6%
Last update: Nov 6, 4:00 PM
Tandem Diabetes Care Inc
TNDMNASDAQ
Tandem Diabetes Care (TNDM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Tandem Diabetes Care (TNDM) last issued guidance on November 5, 2026 for fiscal year 2026. The company guided revenue in the range of $1.06B - $1.08B for the period.
Compared to prior guidance, Tandem Diabetes Care maintained its revenue forecast from a prior range of $1.06B - $1.08B.
Tandem Diabetes Care has issued 20 guidance updates between January 10, 2023 and November 5, 2026. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.33 | $-0.45 | $-0.07 |
| Actual | $-0.10 | $-0.31 | $-0.30 | $-0.01 |
| Surprise | +60.0% | +6.06% | +33.3% | +85.7% |
| Revenue | ||||
| Estimate | $265.7M | $255.0M | $240.2M | $276.7M |
| Actual | $283.7M | $254.6M | $247.2M | $290.4M |
| Surprise | +6.76% | -0.16% | +2.91% | +4.93% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.16 | $-0.13 | $-0.09 | $-0.02 |
| Revenue | ||||
| Consensus | $300.7M | $273.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.10 | $-0.25 | 60.0 % |
| Q2 | Aug 6, 2026 | $-0.31 | $-0.33 | 6.06 % |
| Q1 | May 7, 2026 | $-0.30 | $-0.45 | 33.3 % |
| Q4 | Feb 19, 2026 | $-0.01 | $-0.07 | 85.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $283.69M | $265.74M | 6.76 % |
| Q2 | Aug 6, 2026 | $254.56M | $254.97M | -0.16 % |
| Q1 | May 7, 2026 | $247.22M | $240.22M | 2.91 % |
| Q4 | Feb 19, 2026 | $290.40M | $276.74M | 4.93 % |
